Partners' COI rules overreach

Some employees are raising concerns about conflict-of-interest rules implemented Jan. 1 at Partners Healthcare, owner of Harvard-affiliated hospitals Mass. General and Brigham and Women's.

While some applaud the revamp, the restrictions may be too broad and “could ultimately stifle” critical education, reports the Harvard Crimson.

Industry-sponsored talks, now banned, provide docs with the latest information. Surgical training fellowships may suffer.

“The pendulum is a little too far in one direction,” one professor said. Pharma stock options are forbidden, and outside pay for senior officials has been capped.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.